In vivo characterization of tachykinin receptors responsible for the central cardiovascular effects of substance P and neurokinin A.
Culman
J
J
Department of Pharmacology, University of Heidelberg, Germany.
Tschöpe
C
C
Picard
P
P
Prat
A
A
Regoli
D
D
Couture
R
R
Unger
T
T
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001713:Biphenyl Compounds / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D015288:Neurokinin A / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009842:Oligopeptides / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D018040:Receptors, Neurokinin-1 / Q000187:drug effects / Q000502:physiology*; D018041:Receptors, Neurokinin-2 / Q000187:drug effects / Q000502:physiology*; D013239:Stereotyped Behavior / Q000187:drug effects; D013373:Substance P / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D001713:Biphenyl Compounds; D009842:Oligopeptides; D010446:Peptide Fragments; D018040:Receptors, Neurokinin-1; D018041:Receptors, Neurokinin-2; C063615:neurokinin A (4-10), Tyr(5)-Trp(6,8,9)-Arg(10)-; C076938:R 396; D013373:Substance P; D015288:Neurokinin A; C066892:CP 96345